[ Price : $8.95]
FDA accepts for priority review a Jazz Pharmaceuticals supplemental BLA for Ziihera (zanidatamab-hrii) for use in combination regi...[ Price : $8.95]
A federal judge dismisses a lawsuit brought by homeopathy advocates and a product distributor challenging FDAs decision to tighten...[ Price : $8.95]
Concerns that political pressure could undermine the U.S. drug approval system intensify this week after a new White House directi...[ Price : $8.95]
FDA announces several actions aimed at accelerating the development of treatments for serious mental illness, following a recent e...[ Price : $8.95]
A recent FDA Warning Letter signals a broader regulatory focus on how drugmakers use artificial intelligence, according to a new a...[ Price : $8.95]
FDA issues AbbVie a complete response letter for its BLA for trenibotulinumtoxinE, an investigational, fast-acting botulinum toxin...[ Price : $8.95]
FDA sends an untitled letter to Incyte Corp., warning that portions of the companys consumer-facing Web site for Niktimvo (axatili...[ Price : $8.95]
CDER's Office of Compliance releases a new annual report showing that it expanded enforcement and oversight activities in 2025.